Keratoconjunctivitis: Clinical Trials

5 trials for Keratoconjunctivitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 5
Phase 22Completed 2

Follow Keratoconjunctivitis: new trials by email Literature Review of Keratoconjunctivitis trials Research Report on Keratoconjunctivitis

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of INV-102 Ophthalmic Solution in Adults With Moderate Symptomatic Dry Eye Disease
INV-102, Vehicle - Dry Eye Disease
Phase 1 / Phase 2CompletedInvirsa, Inc.842022-08-302026-09-18
A Phase I Study of PP-001 Eye Drops in Healthy Adult Volunteers
PP-001, Placebo - Keratoconjunctivitis, Ocular Surface Disease
Phase 1CompletedPanoptes Pharma GmbH452018-11-202024-01-12
Safety and Efficacy of PG101 for Dry Eye Syndrome
PG101 - Dry Eye Syndrome
Phase 1 / Phase 2CompletedRhodes Pharmaceuticals, L.P.722013-12-012014-03-05
A Safety, Tolerability and Pharmacokinetics Study of R932348 Eye Drops in Patients With Dry Eye Disease
R348 Ophthalmic Solution, 0.2%, R348 Ophthalmic Solution, 0.5%, R348 Ophthalmic Solution, 1.0% - Keratoconjunctivitis Sicca
Phase 1CompletedRigel Pharmaceuticals362012-11-012014-08-04
A Dose-Escalation Study to Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Volunteers, Followed by an Open-Label Evaluation of LX214 in Patients With Keratoconjunctivitis Sicca (KCS)
voclosporin ophthalmic solution - Keratoconjunctivitis Sicca
Phase 1CompletedLux Biosciences, Inc.352009-02-012012-06-22

Narrower conditions

Keratoconjunctivitis Sicca (4)  ·  Dry Eye Syndromes (2)

Broader conditions

Conjunctival Diseases (5)  ·  Conjunctivitis (5)  ·  Corneal Diseases (5)  ·  Eye Diseases (5)  ·  Keratitis (5)  ·  Lacrimal Apparatus Diseases (4)  ·  Dry Eye Syndromes (2)

Interventions

Gels (1)

Sponsors

Invirsa, Inc. (1)  ·  Lux Biosciences, Inc. (1)  ·  Panoptes Pharma GmbH (1)  ·  Rhodes Pharmaceuticals, L.P. (1)  ·  Rigel Pharmaceuticals (1)

Countries

United States (4)  ·  Austria (1)

Top investigators

Gail Torkildsen, M.D. (1)  ·  Gail Torkildsen, MD (1)  ·  Robert Shalwitz, MD (1)